FDA cleared the FRAXION 3.5 Plate System (Various - See Catalog);FRAXION 4.5 Plate System (Various - See Catalog);FRAXION Mini Plate System (Various - See Catalog);FRAXION Bone Screw System (Various - See Catalog) from Ortler Global Tibbi Gerecler Anonim Sirketi on Aug 28, 2026 under K261830, a traditional 510(k). The device falls under product code HRS, Plate, Fixation, Bone, regulated at 21 CFR 888.3030 as a Class 2 device. The review panel was Orthopedic.
FDA logged the submission as received on Jun 2, 2026. The decision came 87 days later, inside the 90 FDA-day goal for a 510(k).
This is the only decision on file for Ortler Global Tibbi Gerecler Anonim Sirketi in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K261830?
K261830 is the FDA 510(k) for FRAXION 3.5 Plate System (Various - See Catalog);FRAXION 4.5 Plate System (Various - See Catalog);FRAXION Mini Plate System (Various - See Catalog);FRAXION Bone Screw System (Various - See Catalog), submitted by Ortler Global Tibbi Gerecler Anonim Sirketi. FDA's decision date was Aug 28, 2026, under product code HRS (Plate, Fixation, Bone).
Who makes the FRAXION 3.5 Plate System (Various - See Catalog);FRAXION 4.5 Plate System (Various - See Catalog);FRAXION Mini Plate System (Various - See Catalog);FRAXION Bone Screw System (Various - See Catalog)?
Ortler Global Tibbi Gerecler Anonim Sirketi, based in Ankara, is the applicant of record for K261830.
How long did the K261830 review take?
FDA received the submission on Jun 2, 2026 and issued its decision on Aug 28, 2026, 87 days later.